Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAdam Frank

About this trial

This study will test how people with OCD respond to a type of noninvasive brain stimulation, repetitive Transcranial Magnetic Stimulation (rTMS), when it is combined with psychotherapy. Participants will either engage in Exposure and Response Prevention (ERP) Therapy or supportive therapy (ST) while receiving rTMS. Biobehavioral data from wearable devices and smartphones will be collected to better predict treatment responses. Participants will also undergo repeat resting state functional Magnetic Resonance Imaging (rsfMRI) in order to assess neural predictors and mechanisms of treatment response.

Eligibility criteria

Qualifiers

Diagnosis of Obsessive-Compulsive Disorder (OCD) as determined by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnostic criteria.

Live in Southern California and be willing to attend in-person to receive repetitive Transcranial Magnetic Stimulation (rTMS) 5 times per week for 6 weeks.

Have completed a prior course of Exposure and Response Prevention (ERP) therapy (at least ten sessions)

Currently take or have previously tried Serotonin Reuptake Inhibitor (SRI) medication for OCD

Disqualifiers

Primary psychiatric diagnosis other than OCD

Active substance use disorder

Active suicidality

Active psychosis

Trial design

Treatments tested in this trial

  • Repetitive Transcranial Magnetic Stimulation (rTMS)
  • Supportive Therapy (ST)
  • Exposure and Response Prevention (ERP) Therapy

Treatment groups

48 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Adam Frank

Lead sponsor

University of Southern California

Sponsor institution